Coastal Carolina Research   Report issue

For profit Phase 2 Phase 3
Founded: Mt Pleasant SC United States (1997)

Organization Overview

First Clinical Trial
2007
NCT00453401
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Coastal Carolina Research Center | Coastal Carolina Research Center, Mt. Pleasant, SC 29464

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anthrax (Phase 2)

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Dyslipidemias (Phase 3)

Herpes Labialis (Phase 2)

Hot Flashes (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 6
  • # of Trial APIs: 7